Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid.
Oshikawa
K
K
Department of Pulmonary Medicine, Jichi Medical School, Tochigi, Japan. oshikatu@jichi.ac.ip
Kuroiwa
K
K
Tokunaga
T
T
Kato
T
T
Hagihara
S I
SI
Tominaga
S I
SI
Sugiyama
Y
Y
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D005260:Female; D006801:Humans; D000072179:Interleukin-1 Receptor-Like 1 Protein; D008565:Membrane Proteins; D011239:Prednisolone / Q000627:therapeutic use; D011506:Proteins / Q000276:immunology*; D011657:Pulmonary Eosinophilia / Q000188:drug therapy / Q000276:immunology*; D011956:Receptors, Cell Surface; D018418:Th2 Cells / Q000276:immunology*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D016207:Cytokines; C079241:IL1RL1 protein, human; D000072179:Interleukin-1 Receptor-Like 1 Protein; D008565:Membrane Proteins; D011506:Proteins; D011956:Receptors, Cell Surface; D011239:Prednisolone